Kliinisen patologian ja oikeuslääketieteen laitos
Department of Pathology and Forensic Medicine

Julkaisut 1991
Publications 1991

1 Aaltomaa S et al. Nuclear morphometry and mitotic indexes as prognostic factors in breast cancer.
2 Aaltomaa S et al. The significance of nuclear morphometric variables as prognostic predictors in breast cancer.
3 Aaltomaa S et al. Prognostic factors in axillary lymphonode negative (pN-) breast carcinomas.
4 Aaltomaa S et al. Hormone receptor status and mitotic activity as risk factors for recurrence and death in female breast carcinoma.
5 Aaltomaa S et al. Prognostic scores combining clinical, histological and morphometric variables in assessment of the disease outcome in female breast cancer.
6 Aaltomaa S et al. Hormone receptors as prognostic factors in female breast cancer.
7 Aaltomaa S et al. Mitotic index (MAI) and volume corrected mitotic index (M/V index) as predictors in breast cancer.
8 Aaltonen M et al. Effects of THA on passive avoidance and spatial performance in quisqualic acid nucleus basalis-lesioned rats.
9 Airaksinen MS et al. Histamine neurons in human hypothalamus: Anatomy in normal and Alzheimer diseased brains.
10 Axell T et al. An update of the classification and diagnostic criteria of oral lesions in HIV infection.
11 Belli L et al. Recurrent condylomata acuminata treated with recombinant interferon alfa-2a: a multicenter double-blind placebo-controlled clinical trial.
12 Chang F et al. Esophageal squamous cell papillomas. Failure to detect HPV DNA by in situ hybridization and polymerase chain reaction.
13 Chang F et al. Human papillomavirus (HPV) infections and their association with oral disease.
14 Eskelinen M et al. Clinical evaluation of a new tumour marker TAG 12 in breast cancer.
15 Eskelinen M et al. Mesenchymoma of the chest wall in children.
16 Eskelinen M et al. Torsion of testis and its appendages in children.
17 Eskelinen M et al. Relation between DNA ploidy, SPF (S-phase fraction), and survival in patients with pancreatic cancer.
18 Eskelinen M et al. Cancer of pancreas: clinical stage, histological grade, surgical therapy and survival.
19 Eskelinen M et al. Prognostic factors in prostatic adenocarcinoma assessed by means of quntitative histology.
20 Eskelinen M et al. DNA ploidy, S-phase fraction and G2 fraction as prognostic determinants in prostatic adenocarcinoma.
21 Eskelinen M et al. Prognosis of pancreatic cancer with special reference of quantitative histology.
22 Eskelinen M et al. TAG 12 expression as a prognostic factor in female breast cancer.
23 Eskelinen MJ et al. The role of nucleolar organiser regions as prognostic factors in breast cancer.
24 Freund TF et al. Pattern of neuronal death in the rat hippocampus after status epilepticus. Relationship to calcium binding protein content and ischemic vulnerability.
25 Halmekytö M et al. Transgenic mice aberrantly expressing human ornithine decarboxylase gene.
26 Harvima IT et al. Quantitation of tryptase and chymase containing mast cells in cutaneous lichen planus.
27 Helminen H et al. Secrets of articular cartilage.
28 Hippeläinen M et al. Genital human papillomavirus lesions of the male sexual partners: the diagnostic accuracy of peniscopy.
29 Ji HX. Human papillomavirus (HPV) infections of the lower female genital tract: biological sprectrum and applicability of different diagnostic methods.
30 Ji HX et al. Prognostic significance of human papillomavirus (HPV) type and nuclear DNA content in invasive cervical cancer.
31 Ji HX et al. Colposcopic analysis of genital human papillomavirus (HPV) infections during an 8-year prospective follow-up.
32 Kallio P et al. A simple isolation of DNA from formalin-fixed, paraffin-embedded samples for PCR.
33 Kellokoski J et al. Cytokeratin pattern in normal and HPV infected oral mucosa in woman with genital HPV infections.
34 Kellokoski J et al. Dot blot hybridization in detection of human papillomavirus (HPV) infections in the oral cavity of women with genital HPV infections.
35 Kurttio P et al. Urinary excretion of ethylenethiourea and kidney morphology in rats after continuous oral exposure to nabam or ethylenethiourea.
36 Lipponen P et al. Volume corrected mitotic index (M/V index) in breast cancer; relation to histological grade and type, clinical stage, and survival.
37 Lipponen P, Eskelinen M. How to count mitoses in bladder cancer grading?
38 Lipponen P, Eskelinen M. Prognostic factors in bladder cancer treated by cystectomy.
39 Lipponen P et al. Prognosis of transitional cell bladder cancer; a multivariate prognostic score for improved prediction.
40 Lipponen P et al. Quatitative histology in prediction of pancreatic cancer.
41 Lipponen P et al. The relationship between DNA flow cytometric data, nuclear morphometric variables and volume corrected mitotic index (M/V index) in transitional cell bladder cancer.
42 Lipponen P et al. Progression and survival in transitional cell bladder cancer. A comparison of established prognostic factors, S phase fraction and DNA ploidy in human bladder cancer.
43 Lipponen P et al. Nucleolar organiser regions (AgNORs) as predictors in transitional cell bladder cancer.
44 Lipponen P et al. The use of immunohistochemically demonstrated c-erb B-2 oncoprotein expression as a procnostic factor in transitional cell carcinoma of the urinary bladder.
45 Lipponen PK et al. Classic prognostic factors, flow cytometric data, nuclear morphometric variables and mitotic indexes as predictors in transitional cell bladder cancer.
46 Lipponen PK, Eskelinen MJ. Nuclear morphometry in grading transitional cell bladder cancer compared with tradiotional histological grading.
47 Lipponen PK et al. Immunohistological staining of human bladder cancer with a tumor marker CA 50: relation to histological grade (WHO), clinical stage (UICC), and survival.
48 Lipponen PK et al. Intratumoural heterogenity of DNA indices in transitional cell bladder cancer: relation to tumour histology.
49 Lipponen PK et al. Prediction of recurrence and prognosis of T1-2 GI-II transitional cell bladder cancer; evaluation by histoquantitative methods and classic prognosticators.
50 Maw RD et al. Comparison of interferon alpha-2a and podophyllin in the treatment of primary condylomata acyminata.
51 Naukkarinen A et al. Quantitative analysis of contact sites between mast cells and sensory nerves in cutaneous psoriasis and lichen planus based on a histochemical double staining technique.
52 Naukkarinen A, Syrjänen KJ. Expression of transferrin, lactoferrin and breast carcinoma antigen in infiltrating breast carcinomas as related to tumor differentation and hormone receptor status.
53 Nuutinen J et al. View from beneath: Pathology in focus bilateral acinic cell tumours of the parotid gland.
54 Riekkinen M et al. Comparison of quisqualic and ibotenic acid nucleus basalis magnocellularis lesions on water-maze and passive avoidance performance.
55 Riekkinen P Jr et al. Tetrahydroaminoacridine alleviates medial septal lesion-induced and age-related spatial reference but not working memory deficits.
56 Riekkinen P Jr et al. The effects of THA on scopolamine and nucleus basalis lesion-induced EEG slowing.
57 Riekkinen P Jr et al. Joint modulation of neocortical electrical activity by nicotinic and muscarinic receptors.
58 Riekkinen P Jr et al. Combination of atipamezole and tetrahydroaminoacridine/pilocarpine treatment suppresses high voltage spindle activity in aged rats.
59 Riekkinen P Jr et al. Tetrahydroaminoacridine improves passive avoidance retention defects induced by aging and medial septal lesion but not by fimbria-fornix lesion.
60 Riekkinen P Jr et al. Comparison of the effects of acute and chronic ibotenic and quisqualic acid nucleus basalis lesioning.
61 Riekkinen P Jr et al. Increased GABAergic transmission aggravates nucleus basalis magnocellularis lesion-induced behavioral deficits.
62 Riekkinen P Jr et al. Effects of alpha2-drugs and pilocarpine on the high-voltage spindle activity of young and aged control and DSP4-lesioned rats.
63 Riekkinen P Jr et al. Effects of THA on passive avoidance retention performance of intact, nucleus basalis, frontal cortex and nucleus basalis + frontal cortex-lesioned rats.
64 Riekkinen P Jr et al. EEG changes induced by acute and chronic quisqualic or ibotenic acid nucleus basalis lesions are stabilized by tacridine.
65 Riekkinen P Jr et al. Gammavinylgaba increases high voltage spindle activity in control and nucleus basalis-lesioned rats after sub-chronic treatment.
66 Riekkinen P Jr et al. Pharmacological consequences of cholinergic plus serotonergic manipulations.
67 Riekkinen P Jr et al. Effects of atipamezole and tetrahydroaminoacridine on nucleus basalis lesion-induced EEG changes.
68 Saarikoski S et al. Administration sequentille de norethisterone et de progesterone naturelle orale au cours des troubles du cycle menstruel en premenopause.
69 Shen Q et al. A preliminary report of nutritional intervention in dysplasia of the esophagus (in Chinese).
70 Shen Q et al. Compound riboflavin used in nutritional intervention of esophageal dysplasia: a long term study.
71 Syrjänen K. Human papillomavirus infection of the female genital tract. (Editorial).
72 Syrjänen KJ. Papillomavirus infections - Histology and cytology of genital infections.
73 Syrjänen KJ. Genital human papilloma virus infections in HIV-infected males amd females.
74 Syrjänen S. Suun limakalvosairaudet.
75 Syrjänen S et al. The use of polymerase chain reaction in generation of biotinylated human papillomavirus DNA probes for in situ hybridization.
76 Syrjänen S et al. Short biotinylated oligonucleotides bind non-specifically to senile plaques of Alzheimer's disease.
77 Syrjänen S, Kellokoski J. Oral manifestations of HPV infection.
78 Tervahauta A et al. Immunohistochemical demonstration of c-erb B-2 oncoprotein expression in female breast cancer and its prognostic significance.
79 Valjakka A et al. Evoked field responses and awake immobility-related non-rhythmical EEG in hippocampus of young and aged rats.
80 Valjakka A et al. Evoked field responses, recurrent inhibition, long-term potentiation and immobility-related nonrhytmical EEG in the dentate gyrus of fimbria-fornix-lesioned and control rats.
81 Valjakka A et al. Modulation of EEG rhytmicity and spike activity in the rat hippocampus by systemically administered tetrahydroaminoacridine, scopolamine and atipamezole.
82 Van Ranst M et al. A papillomavirus related to HPV type 13 in oral focal epithelial hyperplasia in the pygmy chimpanzee.
83 Viluksela M, Kosma V-M. Dithranol (anthralin)-induced skin irritation in sencar, C57 BL/6 and NMRI mice.
84 Yang XM et al. CO2 gas perfusion: improved efficiendy and safety with sapphire-probe laser ablation of human artery.
85 Yang XM et al. Laser ablation ability of the sapphire probe: an experimental comparison with different laser fiber tips.
86 Ylinen A et al. Hippocampal mobility-related theta activity is not diminished by Vigabatrin, a GABAmimetic antiepileptic drug, in normal rats.
87 Ylinen A et al. Behavioural, electrophysiological and histopatological changes following sustained stimulation of the perforant pathway input to the hippocampus: effect of the NMDA receptor antagonist..
88 Ylinen A et al. Vigabatrin pre-treatment prevents hilar symatostatin cell loss and the development of interictal spiking activity following sustained simulation of the perforant path.
89 Ylinen EMA et al. Enhanced GABAergic inhibition preserves hippocampal structure and function in a model of epilepsy.
90 Yliskoski M. Genital human papillomavirus (HPV) infections. Natural history and treatment of the disease.
91 Yliskoski M et al. Conization for CIN associated with human papillomavirus infection.
92 Yliskoski M et al. Systemic alpha-interferon (Wellferon) treatment of genital human papillomavirus (HPV) type 6, 11, 16, and 18 infections: double-blind, placebo-controlled trial.

Kliinisen patologian ja oikeuslääketieteen laitos Department of Pathology and Forensic Medicine
Julkaisutietokanta 22.05.1997 Publications Data Base 22.05.1997